<DOC>
	<DOC>NCT00909402</DOC>
	<brief_summary>The purpose of this study is to determine the maximum tolerated dose (MTD) of BMS-833923 administered in combination with Cisplatin and Capecitabine as first-line therapy in subjects with inoperable metastatic gastric, gastroesophageal or esophageal adenocarcinomas.</brief_summary>
	<brief_title>A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>For additional information, please contact the BMS oncology clinical trial information service at 8552160126 or email MyCancerStudyConnect@emergingmed.com. Please visit www.BMSStudyConnect.com for more information on clinical trial participation. Esophageal, gastric, or gastroesophageal adenocarcinoma that has spread and cannot be treated with surgery. The diagnosis must be confirmed by a trained pathologist. Prior radiation therapy is allowed in certain circumstances discuss with your doctor. Individuals who have had surgery may be eligible after recovering from the procedure. Individuals who have received chemotherapy for the treatment of their disease within the past 6 months are not eligible. Chemotherapy given more than 6 months ago is permitted. Individuals with spread of their cancer to the brain are permitted in certain circumstances talk with your doctor. Significant heart disease. Women pregnant or breastfeeding. Women able to bear children who are unwilling or unable to use an acceptable method to avoid pregnancy. Uncontrolled medical condition or active infection Inability to swallow pills. Inability to undergo a blood draw, in which a needle is used to obtain blood from a vein in your arm. Individuals receiving another drug not approved by the Food and Drug Administration (FDA) or similar agency in another country. Prisoners or individuals currently receiving treatment for a mental or physical illness as an inpatient in a hospital. Individuals who have experienced pancreatitis, an inflammation of the pancreas, in the past, or who have had a computed axial tomography (CT) scan showing pancreatitis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>